Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-29

Clinical Trial Update: Swiss Dermatology Network of Targeted Therapies (SDNTT)

View source ↗

Summary

A clinical trial update announcing that the Swiss Dermatology Network for Targeted Therapies (SDNTT) is recruiting participants for a Psoriasis study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Swiss Dermatology Network for Targeted Therapies | Conditions: Psoriasis | Status: RECRUITING